Polypharmacy Increased in Psoriatic Arthritis
Psoriatic arthritis (PsA) is plagued by obesity, depression and increased comorbidities; now it appears that polypharmacy adds to the burden of managing PsA.
A study of 11,984 PsA patients in the German BARMER health insurance database from 2021 compared medicines and comorbidities
Read Article